2 completed, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow Sabyasachi Sen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Semaglutide on CD34+ EPC and Fat Derived MSC Semaglutide, Placebos - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Sabyasachi Sen | 10 | 2019-08-01 | 2025-09-09 |
| Effect on HIV Medications on EPC Cells Tenofovir, Rilpivirine, Prezcobix - AIDS | Completed | Sabyasachi Sen | 22 | 2018-11-01 | 2022-03-22 | |
| Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus Dapagliflozin 10mg, Saxagliptin 5mg, Placebo Oral Tablet - Diabetes Mellitus, Type 2, Cardiovascular Diseases | Phase 4 | Terminated | Sabyasachi Sen | 15 | 2018-10-22 | 2023-06-05 |
Diabetes Mellitus, Type 2 (2) · Acquired Immunodeficiency Syndrome (1) · Cardiovascular Diseases (1)
Rilpivirine (1) · Tenofovir (1) · cobicistat mixture with darunavir (1) · dapagliflozin (1) · dolutegravir (1) · saxagliptin (1) · semaglutide (1)
United States (3)